Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors
Nature Biotechnology · 2025-09 · 43 (9) · 1496-1509
DOI: 10.1038/s41587-024-02448-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Biotechnology, online erschienen am 24.10.2024. Verfasst von Yuyan Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Gold, RNA, Small Interfering, Radiosurgery, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI), NIDCR NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
- Department of Pathology, Stanford University, Stanford, CA, USA.
- Department of Comparative Medicine, Stanford University, Stanford, CA, USA.
- Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
- Department of Pathology and Laboratory Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA.
- Veterans Affairs Northern California Health Care System, Mather, CA, USA.
Förderung
- NCI NIH HHS
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- NIDCR NIH HHS
- BLRD VA
- U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)
Zitieren
APA
Jiang, Y., Cao, H., Deng, H., Guan, L., Langthasa, J., Colburg, D. R. C., Melemenidis, S., Cotton, R. M., Aleman, J., Wang, X. J., Graves, E. E., Kalbasi, A., Pu, K., Rao, J., & Le, Q. T. (2025). Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors. Nature Biotechnology, 43(9), 1496-1509. https://doi.org/10.1038/s41587-024-02448-0
Vancouver
Jiang Y, Cao H, Deng H, Guan L, Langthasa J, Colburg DRC, et al. Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors. Nature Biotechnology. 2025;43(9):1496-1509. doi:10.1038/s41587-024-02448-0
BibTeX
@article{Jiang2025,
author = {Jiang, Yuyan and Cao, Hongbin and Deng, Huaping and Guan, Li and Langthasa, Jimpi and Colburg, Deana Rae Crystal and Melemenidis, Stavros and Cotton, Renee M and Aleman, John and Wang, Xiao-Jing and Graves, Edward E and Kalbasi, Anusha and Pu, Kanyi and Rao, Jianghong and Le, Quynh-Thu},
title = {Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors},
journal = {Nature Biotechnology},
year = {2025},
volume = {43},
number = {9},
pages = {1496--1509},
doi = {10.1038/s41587-024-02448-0}
}
EUVIMED